Literature DB >> 17386074

Differential binding characteristics of native monomeric and polymeric immunoglobulin A1 (IgA1) on human mesangial cells and the influence of in vitro deglycosylation of IgA1 molecules.

Y-H Gao1, L-X Xu, J-J Zhang, Y Zhang, M-H Zhao, H-Y Wang.   

Abstract

Recent studies had demonstrated that serum and mesangial immunoglobulin A1 (IgA1) in patients with IgA nephropathy (IgAN) were polymeric and deglycosylated. The current study was to investigate the binding characteristics of monomeric and polymeric normal human IgA1 on mesangial cells and the influence of in vitro deglycosylation of IgA1 molecules. The normal human IgA1 was desialylated and degalactosylated with specific enzymes, respectively. The monomeric IgA1 (mIgA1) and polymeric IgA1 (pIgA1) were separated by Sephacryl S-300 chromatography. The binding capacities of the mIgA1 and pIgA1 to primary human mesangial cells (HMC) were evaluated by classical radioligand assay. Both the native mIgA1 and pIgA1 could bind to HMC in a dose-dependent and saturable manner. The maximal binding capacity of the native pIgA1 were significantly higher than that of the native mIgA1 (P < 0.05). However, the affinity of the native mIgA1 was almost 100 times higher than that of the native pIgA1. After deglycosylation, binding of the two deglycosylated mIgA1 to HMC could not be detected. However, the maximal binding capacities of the two deglycosylated pIgA1 to HMC were increased significantly compared with that of native pIgA1. The affinity of the two deglycosylated pIgA1 was similar to that of native pIgA1 (P > 0.05). The current study suggests differential binding characteristics of native monomeric and polymeric IgA1 on mesangial cells. Glycosylation of IgA1 molecules could significantly affect the binding of IgA1 on HMC.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17386074      PMCID: PMC1941933          DOI: 10.1111/j.1365-2249.2007.03374.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  39 in total

1.  Mesangial IgA1 in IgA nephropathy exhibits aberrant O-glycosylation: observations in three patients.

Authors:  A C Allen; E M Bailey; P E Brenchley; K S Buck; J Barratt; J Feehally
Journal:  Kidney Int       Date:  2001-09       Impact factor: 10.612

2.  The glycans deficiencies of macromolecular IgA1 is a contributory factor of variable pathological phenotypes of IgA nephropathy.

Authors:  L-X Xu; Y Yan; J-J Zhang; Y Zhang; M-H Zhao
Journal:  Clin Exp Immunol       Date:  2005-12       Impact factor: 4.330

3.  Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy.

Authors:  Y Hiki; H Odani; M Takahashi; Y Yasuda; A Nishimoto; H Iwase; T Shinzato; Y Kobayashi; K Maeda
Journal:  Kidney Int       Date:  2001-03       Impact factor: 10.612

4.  Aberrantly glycosylated serum IgA1 are closely associated with pathologic phenotypes of IgA nephropathy.

Authors:  Li-Xia Xu; Ming-Hui Zhao
Journal:  Kidney Int       Date:  2005-07       Impact factor: 10.612

5.  Neuraminidase treatment abrogates the binding abnormality of IgA1 from IgA nephropathy patients and the differential charge distribution of its alpha-heavy chains.

Authors:  O H Hashim; A S Shuib; C T Chua
Journal:  Nephron       Date:  2001-12       Impact factor: 2.847

6.  Charge-dependent binding of polymeric IgA1 to human mesangial cells in IgA nephropathy.

Authors:  J C Leung; S C Tang; M F Lam; T M Chan; K N Lai
Journal:  Kidney Int       Date:  2001-01       Impact factor: 10.612

7.  Identification of a novel Fcalpha receptor expressed by human mesangial cells.

Authors:  J Barratt; M R Greer; I Z Pawluczyk; A C Allen; E M Bailey; K S Buck; J Feehally
Journal:  Kidney Int       Date:  2000-05       Impact factor: 10.612

8.  Absence of CD89, polymeric immunoglobulin receptor, and asialoglycoprotein receptor on human mesangial cells.

Authors:  Joseph C K Leung; Anita W L Tsang; Daniel T M Chan; Kar Neng Lai
Journal:  J Am Soc Nephrol       Date:  2000-02       Impact factor: 10.121

9.  Self-aggregated deglycosylated IgA1 with or without IgG were associated with the development of IgA nephropathy.

Authors:  Y Yan; L-X Xu; J-J Zhang; Y Zhang; M-H Zhao
Journal:  Clin Exp Immunol       Date:  2006-04       Impact factor: 4.330

10.  Identification of the transferrin receptor as a novel immunoglobulin (Ig)A1 receptor and its enhanced expression on mesangial cells in IgA nephropathy.

Authors:  I C Moura; M N Centelles; M Arcos-Fajardo; D M Malheiros; J F Collawn; M D Cooper; R C Monteiro
Journal:  J Exp Med       Date:  2001-08-20       Impact factor: 14.307

View more
  6 in total

1.  The combined role of galactose-deficient IgA1 and streptococcal IgA-binding M Protein in inducing IL-6 and C3 secretion from human mesangial cells: implications for IgA nephropathy.

Authors:  Roland Schmitt; Anne-Lie Ståhl; Anders I Olin; Ann-Charlotte Kristoffersson; Johan Rebetz; Jan Novak; Gunnar Lindahl; Diana Karpman
Journal:  J Immunol       Date:  2014-05-21       Impact factor: 5.422

2.  Histone deacetylase inhibitors attenuate P-aIgA1-induced cell proliferation and extracellular matrix synthesis in human renal mesangial cells in vitro.

Authors:  Qin Dai; Jian Liu; Yun-lei Du; Xu Hao; Ji Ying; Yun Tan; Li-qun He; Wei-ming Wang; Nan Chen
Journal:  Acta Pharmacol Sin       Date:  2016-01-18       Impact factor: 6.150

3.  Synergistic effect of mesangial cell-induced CXCL1 and TGF-β1 in promoting podocyte loss in IgA nephropathy.

Authors:  Li Zhu; Qingxian Zhang; Sufang Shi; Lijun Liu; Jicheng Lv; Hong Zhang
Journal:  PLoS One       Date:  2013-08-30       Impact factor: 3.240

4.  Serum under-O-glycosylated IgA1 level is not correlated with glomerular IgA deposition based upon heterogeneity in the composition of immune complexes in IgA nephropathy.

Authors:  Kenji Satake; Yoshio Shimizu; Yohei Sasaki; Hiroyuki Yanagawa; Hitoshi Suzuki; Yusuke Suzuki; Satoshi Horikoshi; Shinichiro Honda; Kazuko Shibuya; Akira Shibuya; Yasuhiko Tomino
Journal:  BMC Nephrol       Date:  2014-06-13       Impact factor: 2.388

5.  Increased plasma sVCAM-1 is associated with severity in IgA nephropathy.

Authors:  Li Zhu; Sufang Shi; Lijun Liu; Jicheng Lv; Hong Zhang
Journal:  BMC Nephrol       Date:  2013-01-22       Impact factor: 2.388

6.  O- and N-Glycosylation of Serum Immunoglobulin A is Associated with IgA Nephropathy and Glomerular Function.

Authors:  Viktoria Dotz; Alessia Visconti; Hannah J Lomax-Browne; Florent Clerc; Agnes L Hipgrave Ederveen; Nicholas R Medjeral-Thomas; H Terence Cook; Matthew C Pickering; Manfred Wuhrer; Mario Falchi
Journal:  J Am Soc Nephrol       Date:  2021-06-14       Impact factor: 14.978

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.